Stay updated with breaking news from Cyte Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Crystal Amber Fund Ltd - invests in small and mid-cap UK...
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--#RP--jCyte, Inc., a pioneering biotechnology company dedicated to preserving and restoring vision in patients with retinitis pigmentosa (RP) and other degenerative retinal disorders, is pleased to announce the successful outcome of its pre-phase 3 Type B meeting with the US Fo...
The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- Downing Renewables & Infrastructure - investor in solar...
MaxCyte Inc on Tuesday said that promising returns from its strategic platform licence program had bolstered its quarterly revenue expectations. MaxCyte is a Maryland, US-based provider of cell...
MaxCyte Inc (NASDAQ: MXCT) shares are trading higher by over 9% after the company disclosed strong preliminary Q4 and full-year